{
    "organizations": [],
    "uuid": "418ba7f89c0d9ee8832bf046c84653c341fc269f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-richter-says-ema-started-evaluatio/brief-richter-says-ema-started-evaluation-of-its-biosimilar-product-idUSS0N1HL010",
    "ord_in_thread": 0,
    "title": "BRIEF-Richter says EMA started evaluation of its biosimilar product",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt :\n* European Medicines Agency (EMA) has accepted Richterâ€™s regulatory resubmission for its biosimilar pegfilgrastim\n* resubmission follows successful completion of an additional clinical study, Richter says\n* biosimilar pegfilgrastim has been developed by Richter Further company coverage: (Reporting by Krisztina Than)\n ",
    "published": "2018-03-02T16:38:00.000+02:00",
    "crawled": "2018-03-03T17:25:51.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "richter",
        "gedeon",
        "vegyeszeti",
        "gyar",
        "nyrt",
        "european",
        "medicine",
        "agency",
        "ema",
        "accepted",
        "richter",
        "regulatory",
        "resubmission",
        "biosimilar",
        "pegfilgrastim",
        "resubmission",
        "follows",
        "successful",
        "completion",
        "additional",
        "clinical",
        "study",
        "richter",
        "say",
        "biosimilar",
        "pegfilgrastim",
        "developed",
        "richter",
        "company",
        "coverage",
        "reporting",
        "krisztina"
    ]
}